There have been seven new drug products brought to market already in 2014 in Canada (excluding influenza vaccine formulations), five of which are specialty drugs. Last year, 63% of new products approved by Health Canada were specialty products, according to the Cubic Health Canadian Drug Database.
That being said, these are game-changing drugs for many hepatitis C patients, and that term is not used lightly when discussing this disease. In the past few days, I have fielded six calls on the medication from plan sponsors and advisors seeing it hit their plans for the first time.
Also read: Canada "toonie" coin glows in the dark